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Abstract This study explores the attitudes of parents of chil-
dren with Down syndrome towards non-invasive prenatal test-
ing (NIPT) and widening the scope of prenatal screening.
Three focus groups (n = 16) and eleven individual interviews
with Dutch parents (and two relatives) of children with Down
syndrome were conducted. Safety, accuracy and earlier testing
were seen as the advantages of NIPT. Some participants were
critical about the practice of screening for Down syndrome,
but acknowledged that NIPT enables people to know whether
the fetus is affected and to prepare without risking miscar-
riage. Many feared uncritical use of NIPT and more abortions
for Down syndrome. Concerns included the consequences for
the acceptance of and facilities for children with Down syn-
drome, resulting in more people deciding to screen.
Participants stressed the importance of good counseling and
balanced, accurate information about Down syndrome.
Testing for more disorders might divert the focus away from
Down syndrome, but participants worried about Bwhere to
draw the line^. They also feared a loss of diversity in society.
Findings show that, while parents acknowledge that NIPT
offers a better and safer option to know whether the fetus is
affected, they also have concerns about NIPT’s impact on the
acceptance and care of children with Down syndrome.
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Introduction
Non-invasive prenatal testing (NIPT) using cell-free placental
DNA is increasingly being used to test for fetal aneuploidy. By
using a maternal blood sample, NIPT can test for Down syn-
drome with a sensitivity of more than 99 % and a false-
positive rate of less than 0.1 % (Gil et al. 2015). For women
with an elevated risk based on the first-trimester combined test
(FCT), NIPT is a safe alternative to invasive testing, although
invasive testing will be required to confirm a positive NIPT
result. Due to its high accuracy, NIPT can also be used as a
first-tier screening test for all pregnant women, thereby replac-
ing the FCT (Benn et al. 2015), although the positive predic-
tive value is significantly lower in lower-risk women as com-
pared to high-risk women (Norton et al. 2015). The introduc-
tion of this innovative test is having great impact on the pre-
natal landscape. Furthermore, it has been proven possible to
scan the whole fetal genome with NIPT (Lo et al. 2010), so
future use is likely to expand to testing for a wider range of
genetic disorders.
Several studies have investigated the attitudes towards
NIPT of important stakeholders such as health professionals
and pregnant women. Overall, these studies show that both
pregnant women (Farrell et al. 2014; Lewis et al. 2013; van
Schendel et al. 2014) and health professionals (Musci et al.
2013; Tamminga et al. 2015) have great interest in NIPT due
to its ability to test early in pregnancy with high accuracy and
no miscarriage risk. However, concerns were expressed about
potential Broutinized^ or uncritical use of NIPT, women feel-
ing pressure to test, and the possible impact of NIPT on
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acceptance of people with a disability (Lewis et al. 2013; van
Schendel et al. 2014). Alongside these concerns, the introduc-
tion of NIPT in routine prenatal care has been criticized
(Kaposy 2013), on the basis of the disability rights critique
(Kaposy 2013; Parens and Asch 2003). It has been argued that
prenatal screening for Down syndrome sends out a message
that emphasizes the negative aspects of living with Down
syndrome, and implementing NIPT runs counter to the hope
of improving attitudes towards Down syndrome (Kaposy
2013).
Very little is known about what parents of children with
Down syndrome think about prenatal screening and, in partic-
ular, about NIPT. Using an online survey, Kellogg et al. (2014)
studied the attitudes of 73 US mothers of children with Down
syndrome towards NIPT. They showed that the majority of
mothers agreed that NIPT should be available to all pregnant
women, and that NIPT was a good thing because it allows
people to prepare themselves for a child with Down syn-
drome. However, most of the mothers also expected NIPT to
cause an increase in pressure to test and in social stigma for
having a child with Down syndrome (Kellogg et al. 2014).
When looking at the attitudes of parents of children with
Down syndrome towards prenatal testing in general, it seems
that most believe prospective parents should have autonomy
and reproductive freedom (Inglis et al. 2012; Scott et al.
2013). However, studies have shown cultural and religious
differences in attitudes towards prenatal testing and termina-
tion of pregnancy amongst parents of children with Down
syndrome (Ahmed et al. 2013; Bryant et al. 2011). A study
of 78 women who had a sibling with Down syndrome showed
that they overall had a positive experience of having a brother
or sister with this condition, but around one-third would still
consider prenatal testing and termination of pregnancy since
they experienced a negative impact on themselves and their
family (Bryant et al. 2005).
Decisions in a national screening system need political
support, thus taking account of many perspectives. Since the
introduction of NIPTcould have an impact on the way society
perceives Down syndrome and the lives of people living with
this condition, it is important to further investigate what par-
ents of children with Down syndrome think about introducing
NIPT into a national prenatal screening system and which
consequences they think this will have. This information can
be used to establish a responsible implementation of NIPT,
taking account of all stakeholder perspectives. This study
therefore addresses the following research questions: 1)
What do parents of children of Down syndrome think are
the advantages and disadvantages of using NIPT for prenatal
screening?; 2) What are important requirements for a respon-
sible NIPT offer according to them?; and 3) What do they
think about widening the scope of prenatal testing with NIPT?
This study was performed in the Netherlands, where the
uptake of prenatal screening for Down syndrome (and trisomy
18 and 13) is relatively low (~27 %) (Schielen 2010) com-
pared to nearby countries like Denmark (90 %) (Ekelund et al.
2011) or England (74 %) (National Health Service 2012). The
low uptake of screening might be partially explained by the
way screening is offered to women, with a clear emphasis on
the Bright not to know,^ women having to pay for FCT
(Crombag et al. 2014), and the rather positive attitudes to-
wards Down syndrome in the Netherlands (Bakker et al.
2012; Crombag et al. 2016).
Methods
A qualitative research design was used. Focus groups were
formed to explore multiple perspectives and to stimulate dis-
cussion. Additional individual, semi-structured interviews
were held to allow for a more private environment to explore
the attitudes and (often emotional) experiences of parents of
children with Down syndrome. Ethical approval for this study
was obtained from the Medical Ethical Committee of the VU
University Medical Center Amsterdam (VUMC). Informed
consent was obtained from all individual participants included
in the study.
Participants
Participants were recruited with help of the Dutch Genetic
Alliance (VSOP). An invitation for participation was
placed on the website of the Dutch Down Syndrome
Foundation (SDS, parent organization). As this produced
no responses, another invitation was placed on a closed
Facebook group consisting of about 900 members sharing
experiences of having a child with Down syndrome. In
total, 58 parents responded to the invitation, and two par-
ents were recruited through the researchers’ network. A
total of 27 people took part in the study; 16 participated
in the three focus groups (each consisting of 5 to 6 par-
ticipants) and 11 in an individual interview. The parents
who participated in the focus groups were not related.
Two of the focus group participants were not parents but
relatives of a child with Down syndrome (sister and aunt).
Participant characteristics are summarized in Table 1. After
three focus groups and 11 interviews no new information
was obtained, and therefore data saturation was reached.
Instrumentation and Procedures
In April 2014 NIPT became available in the Netherlands in
public healthcare as a second-tier screening test. The first two
focus groups were conducted prior to this period, in
September 2013, in a community center in the middle of the
Netherlands (Utrecht). The last focus group was in April
2015 at the VUMC in Amsterdam. The individual interviews
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were conducted by A.K.K. between March and April 2015,
and took place at participants’ home, workplace or by
telephone.
The focus group sessions were conducted using a
semi-structured interview guide based on the one used
in our previous study of pregnant women and their part-
ners (van Schendel et al. 2014). The guide included the
following topics: participants’ perceptions of the current
Down syndrome screening using the FCT and invasive
tests; perceptions of the advantages and disadvantages
of NIPT, especially when NIPT would become available
as a first-tier screening test; and opinions about testing
for a wider range of disorders using NIPT. Via a
PowerPoint presentation, participants were given a brief
explanation of the characteristics of the current screen-
ing program and characteristics of NIPT, including test-
ing for more genetic disorders. The focus groups were
managed by an experienced moderator, together with an
assistant taking notes and observing group interactions.
For the individual interviews, the same semi-structured
interview protocol, with some minor changes, was used.
During the individual interviews, information about the
current screening program and NIPT was provided ver-
bally, supported by illustrations.
Data Analysis
Focus groups and interviews were audiotaped and tran-
scribed verbatim. After transcription, a thematic content
analysis was performed using the qualitative software
program ATLAS.ti 5.2. Responses in the text were cod-
ed independently by R.v.S. and A.K.K., and ranked and
clustered into main topics and subtopics in order to
identify important themes. Themes and codes were
discussed with a third researcher (L.H.), and discrepan-
cies were discussed until consensus was reached.
Representative quotes from the focus groups (FG) and
interviews (I) were translated from Dutch and are pre-
sented to illustrate the themes.
Results
Participants’ own experiences with prenatal testing for Down
syndrome varied widely as did their attitudes towards prenatal
screening and NIPT. Participants discussed four main themes:
NIPT test characteristics; consequences of a lower barrier for
prenatal screening; requirements for a responsible NIPT offer;
and widening the scope of prenatal screening. The findings are
summarized below.
Theme 1: NIPT Test Characteristics: Accuracy, Safety,
Earlier Testing
Although not all participants necessarily agreed with prenatal
screening, their first impressions of NIPT were positive.
Different advantages of NIPT related to its test characteristics
were discussed.
Accuracy and Safety
The high accuracy of NIPT was seen as an advantage, as
participants felt that the test currently used for prenatal


















Mean number of children (range) 2 (0–3) 2 (1–4)




Mean age of child with DS, years (range) 6 (1–17) 6 (1–16)
Prenatal screening during pregnancy of child with DS
Yes:
Low-risk FCT result 2 2
Low-risk FCT result, invasive test after
ultrasound abnormality
1 0
High-risk FCT result, no invasive test 2 0
High-risk FCT result, invasive test 0 1
FCT (result unknown) 1 0
No:
Not interested 5 7
Not offered 3 0
Declined screening because of the costs 0 1
Not applicable: 2b 0
DS=Down syndrome, FCT First-trimester combined test
a Low: elementary school, lower level of secondary school, lower voca-
tional training; Medium: higher level of secondary school, intermediate
vocational training; High: higher vocational training, university
b Two relatives of children with DS, a sister and an aunt
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screening, the FCT, had limited accuracy, causing unnecessary
invasive tests and a false sense of security in women with a
low-risk estimation.
BI had a chance of 1 in 800 [after FCT], well, I had
some friends who had a chance of 1 in 20. They did not
have a child with Down syndrome, and I did. I was
totally not prepared for it, because I actually thought
that my child would not have Down syndrome, because
I had excluded that with the test [FCT].^ (I11)
Participants stated that NIPT’s ability to reduce the number
of invasive procedures, and thus miscarriages, is a great ad-
vantage since these tests are risky and stressful, both for preg-
nant women and obstetricians.
BLower risk of miscarriages, and that is of course, the
big advantage I think […] I have had chorionic villus
sampling, but that’s just not nice. It was a very bad
experience […] it was painful but also emotionally a
bad experience.^ (FG1)
Most participants argued that because NIPT is accurate and
safe, it is easier for women to test whether the fetus has Down
syndrome. In the case of a positive test result, this allows
women to prepare themselves emotionally for the birth of a
child with special needs, arrange adapted perinatal care, or
terminate the pregnancy if they feel they are not able to cope
with a child with Down syndrome.
BFor me that is the biggest advantage, that without the
risk of a miscarriage you know what the situation is and
from there on can think: What do I choose?^ (FG2)
BIf NIPT had been available back then, I would have
liked to have had it, because then at least I would have
known [that the fetus had Down syndrome]. Our child
had a very narrow escape [at birth]; there would have
been less risk if we had known.^ (FG3)
Testing Earlier
The fact that NIPT can test earlier in pregnancy than the FCT
was seen as an advantage because participants expected less
maternal-fetal bonding during the early phase of pregnancy.
Should the fetus have an abnormality, and prospective parents
wish to terminate, it was thought that this would be easier to
deal with because they are less attached to the child.
BYeah I think the earlier you know, the less difficult an
abortion will be probably, for me I think, because a child
develops so quickly […] I think I would be able to live
with it [termination of pregnancy] better if it‘s done as
early as possible.^ (FG2)
Participants also mentioned that testing early in preg-
nancy is better because fewer people are aware of the
pregnancy, which means that a potential termination of
pregnancy would be easier for the parents socially as
they would not have to explain it to others.
While most agreed that earlier testing is an advantage
of NIPT, some argued that this could also be a disad-
vantage. They thought that women (and their partner)
would terminate the pregnancy less thoughtfully since
they are less involved in the pregnancy at this stage,
feel less of a bond with the child, or do not have
enough time to think carefully about what they want.
They expected this could even lead to regret afterwards.
BYou are maybe less involved with your pregnancy. […]
you have thought less well about the consequences of
aborting it, while later on you may feel sorry about it.^
(FG1)
Theme 2: Consequences of a Lower Barrier for Prenatal
Screening
Most participants felt that because of the better test
characteristics, NIPT would lower the barrier for partic-
ipation in prenatal screening. Some saw this as an ad-
vantage since prenatal screening will become easier as
only a blood sample is required, and there is no risk of
miscarriage.
BIt is just more accessible because of the fact that there
is less risk of a miscarriage […] you can just give blood,
so in that sense it is more accessible […] it lowers the
barrier.^ (FG1)
Most participants, however, saw this lessened barrier as a
disadvantage. Since NIPT is such an easy and risk-free test, it
might become more Bnormalized^ to screen for Down syn-
drome, and Down syndrome would become less accepted.
BIt will become more normal to test for Down syndrome
with the consequence that Down syndrome becomes
even more undesirable, because the fact that you screen
for something means it is undesirable, otherwise you
wouldn’t screen for it.^ (FG1)
Moreover, participants thought that pregnant women
and their partner might feel pressured by society to have
NIPT. Participants stated that already with the FCT
some parents of children with Down had the experience
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of being judged on their choice not to screen. Since
NIPT is a better test, women who decline NIPT might
feel the need to explain their decision. Having a child
with Down syndrome might be regarded as their own
responsibility for which society would then be justified
to hold them (financially) accountable.
BYour freedom of choice will be limited in such a way
that you have to explain the fact that you don’t want to
screen.^ (FG3)
BLike, you consciously decided not to test, so it’s kind of
your own fault…so then you also will carry the burden
of it. So everything it [having a child with Down syn-
drome] costs, yeah: Sorry madam, you should been test-
ed then.^ (FG3)
Participants thought that the uptake of prenatal
screening would increase with NIPT, and more people
would terminate their pregnancy. This would cause a
decline of the population with Down syndrome, leading
to a potential loss of acceptance and facilities for affect-
ed individuals. They also were concerned that because
of the decreasing number of people with Down syn-
drome there would be less research on Down
syndrome-related complications, thereby eroding the
knowledge concerning treatments and care for people
with Down syndrome. In this scenario women would
not really have a choice anymore to turn down prenatal
screening, which would lead to an even higher uptake.
This supposed self-reinforcing process is illustrated in
Fig. 1.
BThe moment you make screening more accessible and
lower the barriers [...] more people will do it […], and
as a consequence of that, the population [of people with
Down syndrome] will decline. I am sure of that.^ (FG1)
BWhat has been fought for, for so long, that those people
finally, yeah, are more accepted in society, […] that will
all go, well, it might deteriorate.^ (FG2)
Participants hypothesized that the advantages of NIPT
are mostly applicable to the individual woman. In con-
trast, the disadvantages of NIPT are more likely to af-
fect society as a whole. For example, they feared it
would lead to a loss of diversity in society. They
thought that people with Down syndrome were valuable
to society, and that people could learn from them.
BThe way he [son] has contact with other people,
everybody can take it as an example. […] he gives
a lot of joy, and it sometimes brings you back to
reality.^ (I3)
Participants indicated that having a disability could become
less acceptable by society.
B[Screening] affects people with a disability.[…] There
is a negative attitude towards people with a disability,
and this is stimulated [by the introduction of
NIPT].^(I2)
In addition, participants thought that people may get
the idea that life can be controlled by using NIPT, and
that this might lead to unrealistic expectations about
having children.
BIt’s not like: Okay, I did the test and I am done now, and
everything will be fine. Having a child is not easy, and a
lot of things can be wrong with the child, and there are
external factors that influence child development. Now
[with NIPT] it seems like, well you can exclude every-
thing […]. That’s just not true.^ (I7)
Lastly, participants felt that prenatal screening puts a
lot of focus on Down syndrome, while trisomy 13 and
18 can also be identified. They felt that with NIPT, the
focus is even more on Down syndrome. They stated
that in the (Dutch) media NIPT is being called Bthe
Down-test^ (e.g. van Calmthout 2013), which in their
opinion suggests that Down syndrome is the worst thing
that can happen to your child.
BIt [prenatal screening] makes it seem as if the most
important thing is to avoid having Down syndrome
[…] like, when it [the child] has Down syndrome then
your world will fall apart, there is nothing worse than
that […]. I am not saying it is not a handicap. But it is
not the worst in the world, no.^ (FG2)
Fig. 1 Self-reinforcing process of impact of NIPT, based on expectations
of Dutch parents of children with Down syndrome (DS)
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BActually it’s already becoming standard: NIPT equals
Down syndrome, which equals terminating the
pregnancy.^ (FG3)
Some participants wondered why Down syndrome is still
screened for at all. They felt that people with Down syndrome
can have a valuable life, and that there has been significant
medical progress, giving children with Down syndrome much
fewer medical problems nowadays.
BI support screening if there is something one can do,
and if suffering can be avoided. We therefore did the
FCT because trisomy 13 or 18…we wouldn’t wish that
on a child. But a child with Down syndrome […] overall
can have a valuable life in society.^ (FG3)
BI often wonder for what medical reason they screen for
Down syndrome [..] the reason why those children did
not survive was primarily because of their heart disor-
der, and there has been so much medical progress on
that.^ (FG1)
Theme 3: Requirements for a Responsible NIPT Offer
NIPT in Public Healthcare
Although not all participants agreed with screening for
Down syndrome, most did think it is unrealistic to stop
offering prenatal screening. Therefore, when prenatal
screening is being offered anyway, they felt that it
would be better to screen with a safe and accurate test
like NIPT and to embed this in public healthcare with
proper counseling, instead of women going to a com-
mercial setting where they might receive poor counsel-
ing and information.
BYou’re better off starting to offer it [NIPT] within pub-
lic healthcare and making sure there is proper counsel-
ing than having it offered anyway in some kind of com-
mercial setting.^ (FG1)
Reimbursement of NIPT
Participants had trouble deciding whether NIPT should be
reimbursed. They felt that by doing so, you send out a certain
message that would encourage all people to do this test with-
out thoroughly thinking about it. However, the present cost of
NIPT could create double stigmatization, where children with
Down syndrome are only born in lower social economic clas-
ses, because those people cannot afford NIPT.
BPeople with a low income, yeah, they cannot do it
[NIPT]. Yeah, it will be like when you could recognize
someone’s poverty by the state of his teeth.^ (FG3)
Information and Counseling
Almost all participants mentioned that improving information
provision during the implementation of NIPT is important to
support informed decision-making and avoid routinization.
Participants felt improvement to be necessary because they
thought there was a lack of good counseling and up-to-date,
balanced information about Down syndrome. They also felt
that in society Down syndrome is portrayed as being either too
negative or too optimistic.
BWe are programmed to think it is terrible to have a
child with Down syndrome. But if you see how normal
a child with Down syndrome can be, if you, in some way,
can incorporate that [in counseling], then you get more
balanced information than there is now.^ (FG1)
BThere is a group that portrays it [Down syndrome] as
very positive, but they want to counterbalance all those
negative stories […] I would like to see a midway, the
reality […] just show how it really is, and that is very
diverse.^ (FG1)
Several participants mentioned that the government con-
tributes to the negative image of Down syndrome by provid-
ing the possibility to test for Down syndrome.
BDown syndrome really gets labelled as a disorder that
should not exist. At least, that’s how many parents [of
children with Down syndrome] perceive it, and for that
we blame the government.^ (I9)
They indicated that the government therefore has the re-
sponsibility to correct the negative image of Down syndrome
by, for example, information campaigns, and that the govern-
ment should not spend money on the implementation of a new
test without improving the information provision.
To achieve balanced and complete counseling for NIPT,
many parents stated that, in addition to medical information,
more information about living with Down syndrome should
be given.
BYes, also the counseling, […] I think that obstetricians
and midwives can still learn a lesson about that when
NIPT gets implemented. […] I think counseling is very
important. To portray a realistic picture [of] what it’s
like to live with a child that has a disorder.^ (I10)
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BI think you should highlight all sides [of Down syn-
drome]. The current counseling for Down syndrome is
like ‘high risk of heart disease,’ ‘higher risk for this’
[…] you are just getting a list of symptoms. […] When
you offer it [NIPT] to people, you should also offer all
information […], all sides of it. Make sure that people
really get an honest picture.^ (I6)
Several participantsmentioned that parents of childrenwith
Down syndrome could have a role as an information source.
They could share their experiences of having a child with
Down syndrome and make people understand what it is like.
BNot to convince them [prospective parents], but to tell
the truth, to show the reality.^ (I8)
Some participants also thought there was unfamiliarity
with Down syndrome amongst healthcare professionals.
They were concerned because professionals play a major role
during counseling and can have a significant impact on par-
ents’ decisions, as parents might feel uncertain and anxious
after receiving test results. Some participants also mentioned
that for some obstetricians, a termination of pregnancy is the
obvious next step after a Down syndrome diagnosis.
Participants therefore stressed the importance of a non-
directive attitude of the health professional.
BThat people hear like ‘Well you had amniocentesis, you
carry a child with Down syndrome, so when are we
going to set the appointment to terminate the
pregnancy?’^ (FG1)
BI can imagine that, when you are pregnant and have a
lot of hormones and emotions and whatever, and then
you hear that your child has Down syndrome and you
know nothing about it, then you get the opinion of a
doctor. The question is whether all doctors will have
the same opinion. I think not.^ (I1)
Theme 4: Widening the Scope of Prenatal Screening
with NIPT
Participants had conflicting thoughts about testing for more
disorders with NIPT. They agreed it had a number of advan-
tages, like being able to prevent suffering, to arrange adapted
perinatal care, or starting soon after birth with a certain diet to
lessen the pathology of the disorder.
BIf people indeed happen to have a disorder that you
can, for example, partly prevent with a lifestyle or diet
[…] yeah that of course has its advantages.^ (FG1)
Some participants mentioned that it would give parents the
option to decide whether they would be capable of caring for a
child with a disorder.
BI find the freedom of choice of parents very important.
Like, can I handle this? Will we be able to deal with this
in my family?^ (FG2)
Some participants also felt that testing for more disorders
could lessen the focus on Down syndrome, which they saw as
a benefit.
Moderator: BExpanding the offer [of NIPT] to other
disorders, what do you think about that?^
Respondent: BWell, I think, that as long as it [a broader
NIPT test] goes along with good information
provision...look, what I find wrong at this moment is that
the focus is somuch onDown syndrome […] and if there
will be more [disorders], […] as long as the information
provision is right, everyone should be able to decide for
themselves.^ (FG1)
Participants expected it to be difficult to decide where to
draw the line when testing for a broader range of disorders,
and to avoid that this line getting crossed over time.
BYeah, what would worry me a lot is how to guard that
line […] what we can all test for. We are curious by
nature you know, there will always be people that will
want to cross that line.^ (FG1)
Some participants noted that it is not up to prospective
parents to decide about everything since we cannot control
everything in life. Some also mentioned that society would
not benefit from eliminating everything that differs from the
Bnormal standard.^
BI find it very dangerous that as a society we more and
more make value judgments on everyone who doesn’t fit
the strict definition of normality.^ (FG3)
Other participants mentioned that people would be faced
with even more difficult decisions to deal with during preg-
nancy. Moreover, they worried what kind of impact it would
have on eligibility for healthcare insurance or housing
mortgages.
Discussion
Parents of children with Down syndrome considered the ac-
curacy, safety and possibility to test earlier as advantages of
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using NIPT in prenatal screening. However, they thought that
prenatal screening in general, and the use of NIPT in particu-
lar, put too much focus on Down syndrome, making it seem
like Down syndrome is the worst thing that can happen to
one’s child. They expected that NIPTwould lower the barrier
for participation in screening, which has both advantages and
disadvantages. Participants argued that NIPT gives people a
more accurate option to test for Down syndrome without hav-
ing to risk a miscarriage; but because of that, testing for Down
syndrome and terminating the pregnancy could also become
more normal. They feared the latter could erode the accep-
tance, facilities and research for Down syndrome, which in
turn leaves women with little room to decline testing (self-
reinforcing process illustrated in Fig. 1). Participants stated
that, when implementing NIPT, the counseling should be im-
proved by giving more balanced, accurate information, in-
cluding more information about living with Down syndrome.
Although participants assumed that testing for more disorders
with NIPT diverts the focus away from Down syndrome and
allows for early medical intervention, they worried about
where to draw the line. They also feared a loss of diversity
in society.
This study describes the views of a sample of parents and
relatives of children with Down syndrome in the Netherlands, a
country with relatively low uptake of prenatal screening. When
compared with the attitudes of pregnant women in the
Netherlands as well as pregnant women in other countries
(Farrell et al. 2014; Lewis et al. 2013; van Schendel et al.
2014), it seems that parents of children with Down syndrome
often perceive similar advantages and disadvantages of NIPT.
Like pregnant women, they believe NIPT lessens the barrier for
participation in screening because it is a simple and safe test that
can be done early in pregnancy. Similar to the study by Kellogg
et al. (2014) of mothers of children with Down, participants
agreed the lower barrier is beneficial because it allows people
to test without risk and decide, after confirmation, whether or
not to continue the pregnancy based on that information.
The notion that it could also lead to an increase in termina-
tion of pregnancies also corresponds to findings of Kellogg
et al. (2014), where the majority believed NIPTwould lead to
the termination of more pregnancies. A study by Natoli et al.
(2012) on termination rates after a Down syndrome diagnosis
showed that higher termination rates were associated with
earlier gestational age. This finding supports the assumption
that NIPT’s ability to test earlier could lead to more termina-
tion of pregnancies, although others have suggested that with
NIPT the percentage of women who opt for termination of
pregnancy in the case of an affected pregnancy may decrease
(Verweij et al. 2013).
The fear expressed by participants that fewer children with
Down syndrome being born could lead to stigmatization and
fewer facilities, is a concern that was also observed in several
other studies (Allyse et al. 2015; Haider et al. 2016; Lewis
et al. 2013; van Schendel et al. 2014). Due to the lower barrier
for NIPT, participants indicated that good quality counseling
and informed decision-making are of great importance. This
awareness also exists amongst health professionals, for exam-
ple, genetic counselors from the UK, who stated that because
NIPT has the potential to become routinized, it is the profes-
sional’s role to make sure that women understand what they
are consenting to (Alexander et al. 2014).
To help healthcare professionals facilitate meaningful
discussions between themselves and prospective parents,
Sachs et al. (2015) have developed a framework for pre-
test counseling about NIPT, especially focusing on its ca-
pabilities and limitations. Participants in our study, howev-
er, felt that already in current screening practice, informa-
tion and counseling were not up to standard. They were
especially critical of the quality of the information about
Down syndrome given at different stages of the screening
trajectory. Studies in other countries suggest that knowl-
edge of Down syndrome among healthcare professionals
could be improved (Ternby et al. 2015a), and that some
parents perceive the information about what it may mean
to live with this condition, both for the individual and for
the parents, as insufficient (Carroll et al. 2012; Ternby
et al. 2015b) or overly negative (Kellogg et al. 2014). It
was also noted that the information leaflets for those con-
sidering screening for Down syndrome should provide
more accurate information about this (Saiklang and
Skirton 2015). Participants in our study thought that par-
ents of children with Down syndrome could play a valu-
able role in this respect as well.
Similar to pregnant women (van Schendel et al. 2014),
parents of children with Down syndrome think that testing
for more disorders with NIPT can have some advantages.
Interestingly, one of the advantages mentioned was that it
would shift the focus away from Down syndrome, thus
avoiding the impression of Down syndrome as a disorder for
which screening would somehow be more justified than for
other (including more serious) conditions, something that
many of these parents find unjust and hurtful. Participants,
however, feared testing for more disorders would confront
prospective parents with even more difficult decisions. This
fear was also expressed in our previous questionnaire study of
Dutch pregnant women, who stated that Btesting for a broad
range of disorders may complicate the decision-making pro-
cess beyond what most couples are able to comprehend^ (van
Schendel et al. 2015). Although it was not explicitly men-
tioned in this study, widening the scope of testing will also
make it increasingly difficult to meaningfully discuss prior to
testing what it is like to have a child with any of the conditions
screened for. Participants in our study also feared a loss of
diversity in society, which is in line with findings from a
previous study in the UK that highlighted public fears of fuel-
ing a problematic quest for perfection if NIPTwere to be used
van Schendel et al.
to screen for an ever wider range of disorders (Kelly and
Farrimond 2012).
Study Limitations and Research Recommendations
A strength of this study is the qualitative approach, which
allows for exploring in-depth views about NIPT. Using both
focus groups and individual interviews allowed us to explore
opinions in both a group context and more private environ-
ments, which strengthened the credibility of the results. As far
as we know, this is the first qualitative study of the attitudes of
parents of Down syndrome children towards NIPT. A limita-
tion of the study is that almost all participants were recruited
from one source, a Facebook group which consisted of people
with relatively young children. Moreover, participants were
Caucasian and highly educated. This might have led to biased
responses. Additionally, previous discussions on this
Facebook page might have influenced participants’ opinions.
Moreover, attitudes of parents might have been influenced by
the strongly articulated opinions in the Dutch media. In the
focus group and individual interviews held in 2015, partici-
pants seemed more negative about NIPT than in the focus
groups in 2013. However, the sample size is too small to draw
conclusions on this point. The study was conducted in the
Netherlands, where prenatal testing is offered in a nationally
organized prenatal screening system, the uptake of which is
relatively low. Attitudes of participants in this study may thus
vary from those living in countries where NIPT is offered by
individual (commercial) healthcare providers, or in countries
with other cultures and religions. Finally, qualitative data are
not intended to be generalized to the population of interest.
Future studies might include larger samples of males and fe-
males. Moreover, should NIPT be introduced as a first-tier
screening test, it would be interesting to see whether and
how it affects parents’ opinions.
Conclusion and Practice Implications
The findings from this study provide insight into the expecta-
tions and concerns that parents of children with Down syn-
drome have about introducing NIPT into a national prenatal
screening system. It can be concluded that parents of children
with Down syndrome may have ambivalent attitudes towards
NIPT. While they do not necessarily all agree with prenatal
screening, they do acknowledge that NIPT offers a better op-
tion than the combined test to know whether the fetus has
Down syndrome. However, they also expressed concerns for
the future of children with Down syndrome and emphasized
the need for good counseling and information provision, in-
cluding more information about living with Down syndrome.
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